INTRODUCTION: The effects of multiple inherited and acquired thrombophilicdefects on the outcome of in-vitro fertilization (IVF) remain unexplored. The aimof this study was to evaluate the association between multiple thrombophilia and clinical outcomes in a large prospective cohort of women undergoing IVF.MATERIALS AND METHODS: Consecutive women scheduled for IVF were eligible. Theprimary study outcome was live birth. Secondary outcomes included spontaneousabortion, clinical pregnancy, and symptomatic venous thromboembolism.RESULTS: 687 women with a mean age of 34.6 (±3.2) years were included. Overall,22 women (3.2%) had two or more thrombophilic defects. The probability of livebirth was not statistically significantly different between women with ≥2thrombophilia (odds ratio [OR] 0.62; 95% confidence interval [CI], 0.18 to 2.11) or ≥1 thrombophilia (OR 0.67;95% CI, 0.41 to 1.09) and women without anythrombophilia. None of the individual inherited thrombophilia nor positivity toantiphospholipid antibodies or lupus anticoagulant were associated with livebirth. Single positivity for lupus anticoagulant carried a more than threefoldhigher risk of abortion (OR 3.74; 95% CI, 1.30 to 10.75). There were nostatistically significant associations between individual or multiplethrombophilic defects and clinical pregnancy or pregnancy test results. No woman had a history of venous thromboembolism and none developed a thrombotic eventduring the study.CONCLUSIONS: In women undergoing IVF, the presence of two or more thrombophilicdefects was rare and showed no statistically significant associations with IVFoutcomes.
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization
Rutjes, Anne Wilhelmina Saskia;
2018-01-01
Abstract
INTRODUCTION: The effects of multiple inherited and acquired thrombophilicdefects on the outcome of in-vitro fertilization (IVF) remain unexplored. The aimof this study was to evaluate the association between multiple thrombophilia and clinical outcomes in a large prospective cohort of women undergoing IVF.MATERIALS AND METHODS: Consecutive women scheduled for IVF were eligible. Theprimary study outcome was live birth. Secondary outcomes included spontaneousabortion, clinical pregnancy, and symptomatic venous thromboembolism.RESULTS: 687 women with a mean age of 34.6 (±3.2) years were included. Overall,22 women (3.2%) had two or more thrombophilic defects. The probability of livebirth was not statistically significantly different between women with ≥2thrombophilia (odds ratio [OR] 0.62; 95% confidence interval [CI], 0.18 to 2.11) or ≥1 thrombophilia (OR 0.67;95% CI, 0.41 to 1.09) and women without anythrombophilia. None of the individual inherited thrombophilia nor positivity toantiphospholipid antibodies or lupus anticoagulant were associated with livebirth. Single positivity for lupus anticoagulant carried a more than threefoldhigher risk of abortion (OR 3.74; 95% CI, 1.30 to 10.75). There were nostatistically significant associations between individual or multiplethrombophilic defects and clinical pregnancy or pregnancy test results. No woman had a history of venous thromboembolism and none developed a thrombotic eventduring the study.CONCLUSIONS: In women undergoing IVF, the presence of two or more thrombophilicdefects was rare and showed no statistically significant associations with IVFoutcomes.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.